Galmed Pharmaceuticals
(NASDAQ) GLMD
Galmed Pharmaceuticals Financials at a Glance
Market Cap
$4.99M
Revenue (TTM)
$0.00
Net Income (TTM)
$10.31M
EPS (TTM)
$-2.33
P/E Ratio
-0.32
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$0.74
Volume
288,429
Open
$0.72
Price
$0.74
Volume
288,429
Open
$0.72
Previous Close
$0.76
Daily Range
$0.71 - $0.76
52-Week Range
$0.41 - $2.68
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$0.74
Volume
288,429
Open
$0.72
Previous Close
$0.76
Daily Range
$0.71 - $0.76
52-Week Range
$0.41 - $2.68
GLMD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Galmed Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Allen J. Baharaff
Website
galmedpharma.comHeadquarters
Ramat Gan, 6578317, IL
GLMD Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-64%
Return on Capital
-54%
Return on Assets
-55%
Earnings Yield
-3.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.99M
Shares Outstanding
6.60M
Volume
288.43K
Short Interest
0.00%
Avg. Volume
3.03M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$8.51M
EBITDA
$8.51M
Operating Cash Flow
$6.32M
Capital Expenditure
$0.00
Free Cash Flow
$6.32M
Cash & ST Invst.
$18.16M
Total Debt
$0.00
Galmed Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.99M
N/A
Market Cap/Employee
$1.66M
N/A
Employees
3
N/A
Net Income
$4.82M
-50.1%
EBITDA
$3.04M
-85.0%
Quarterly Fundamentals
Net Cash
$18.16M
+18.4%
Accounts Receivable
$80.00K
-61.7%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-55.34%
N/A
Return on Invested Capital
-53.92%
N/A
Free Cash Flow
$1.95M
+1.2%
Operating Cash Flow
$1.95M
+1.2%